InceptionR’s Emergent Biosolutions EBS Stock Holding History

InceptionR’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-30,243	Closed	-$253K	–	680
2024 Q3	$253K	Buy	+30,243	New	+$275K	0.06%	507

Other funds holding EBS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OHA

Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return

InceptionR's EBS Position: Q4 2024 in Review

InceptionR sold out of Emergent Biosolutions (EBS) in Q4 2024, closing a stake of 30,243 shares — an estimated $253K sold.

InceptionR first reported a position in EBS in Q3 2024 and held it in 1 quarter. The position peaked at $253K in Q3 2024. 156 funds tracked by Wall St. Rank hold EBS as of Q4 2024.

InceptionR reported no remaining Emergent Biosolutions position as of Q4 2024 after selling out during the quarter.
InceptionR sold 30,243 Emergent Biosolutions shares in Q4 2024, an estimated $253K.
InceptionR first reported a position in Emergent Biosolutions in Q3 2024 and held it in 1 quarter.
InceptionR's Emergent Biosolutions position peaked at $253K in Q3 2024.
156 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2024.

Based on InceptionR's 13F filing for Q4 2024, filed 6 Feb 2025.